• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

为什么哮喘可能出人意料地保护 COVID-19 患者免受不良结局影响。

Why asthma might surprisingly protect against poor outcomes in COVID-19.

机构信息

National Heart and Lung Institute, Imperial College, London, UK.

National Heart and Lung Institute, Imperial College, London, UK

出版信息

Eur Respir J. 2020 Dec 10;56(6). doi: 10.1183/13993003.03045-2020. Print 2020 Dec.

DOI:10.1183/13993003.03045-2020
PMID:33154034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7651838/
Abstract

https://bit.ly/3eiXOPP

摘要

[网页链接]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ca/7651838/32fc50343923/ERJ-03045-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ca/7651838/32fc50343923/ERJ-03045-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ca/7651838/32fc50343923/ERJ-03045-2020.01.jpg

相似文献

1
Why asthma might surprisingly protect against poor outcomes in COVID-19.为什么哮喘可能出人意料地保护 COVID-19 患者免受不良结局影响。
Eur Respir J. 2020 Dec 10;56(6). doi: 10.1183/13993003.03045-2020. Print 2020 Dec.
2
Covid-19: reduced asthma presentations in children.新冠病毒-19：儿童哮喘就诊病例减少
BMJ. 2020 Jul 15;370:m2806. doi: 10.1136/bmj.m2806.
3
Asthma and COPD in Hospitalized COVID-19 Patients.住院COVID-19患者中的哮喘和慢性阻塞性肺疾病
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
4
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.住院哮喘患者的 SARS-CoV-2 肺炎并未引发严重恶化。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2600-2607. doi: 10.1016/j.jaip.2020.06.032. Epub 2020 Jun 27.
5
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?哮喘与新冠病毒病：哮喘是导致严重后果的风险因素吗？
Allergy. 2020 Jul;75(7):1543-1545. doi: 10.1111/all.14348.
6
Does asthma affect morbidity or severity of COVID-19?哮喘是否会影响新型冠状病毒肺炎的发病率或严重程度？
J Allergy Clin Immunol. 2020 Jul;146(1):55-57. doi: 10.1016/j.jaci.2020.05.017. Epub 2020 May 26.
7
Pediatric Hospitalizations During the COVID-19 Pandemic.新冠疫情期间的儿科住院情况
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-005983. Epub 2020 Nov 3.
8
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.RT-PCR 检测的、无需住院的 SARS-CoV-2 感染患者中的哮喘患病率。
Respir Med. 2020 Sep;171:106084. doi: 10.1016/j.rmed.2020.106084. Epub 2020 Jul 4.
9
Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.西班牙马德里新冠肺炎住院患者中合并2型疾病的哮喘患者的患病率、特征及结局
J Investig Allergol Clin Immunol. 2020;30(5):382-384. doi: 10.18176/jiaci.0627. Epub 2020 Jun 18.
10
The Indirect Impact of COVID-19 on Children With Asthma.新冠病毒病对哮喘儿童的间接影响
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):768-769. doi: 10.1016/j.arbres.2020.07.003. Epub 2020 Aug 17.

引用本文的文献

1
TSLP pretreatment inhibits M1 macrophage polarization and attenuates LPS-induced iNKT cell-dependent acute lung injury.TSLP预处理可抑制M1巨噬细胞极化，并减轻脂多糖诱导的iNKT细胞依赖性急性肺损伤。
Front Immunol. 2025 May 23;16:1583235. doi: 10.3389/fimmu.2025.1583235. eCollection 2025.
2
Characterizing the Association Between Asthma and Clinical Outcomes in Emergency Department Patients With Symptomatic COVID-19.对有症状的COVID-19急诊科患者中哮喘与临床结局之间的关联进行特征描述。
Cureus. 2025 Feb 25;17(2):e79657. doi: 10.7759/cureus.79657. eCollection 2025 Feb.
3
Association between asthma and COVID-19 severity during Omicron epidemic: a retrospective cohort study using real-world data.

本文引用的文献

1
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.吸入性皮质类固醇通过抑制 I 型干扰素下调 COPD 中 SARS-CoV-2 受体 ACE2。
J Allergy Clin Immunol. 2021 Feb;147(2):510-519.e5. doi: 10.1016/j.jaci.2020.09.034. Epub 2020 Oct 15.
2
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.需要住院的 COVID-19 肺炎合并哮喘患者的特征和结局。
Eur Respir J. 2020 Nov 5;56(5). doi: 10.1183/13993003.01875-2020. Print 2020 Nov.
3
COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
奥密克戎流行期间哮喘与 COVID-19 严重程度的关联：使用真实世界数据的回顾性队列研究。
BMC Infect Dis. 2024 Jul 4;24(1):667. doi: 10.1186/s12879-024-09520-9.
4
Spatial Survival Model for COVID-19 in México.墨西哥新冠肺炎的空间生存模型
Healthcare (Basel). 2024 Jan 24;12(3):306. doi: 10.3390/healthcare12030306.
5
Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog.细菌蛋白酶作为新冠病毒感染潜在可利用的调节剂：来自文献的逻辑、信息学以及犬类的启示
BioTech (Basel). 2023 Oct 30;12(4):61. doi: 10.3390/biotech12040061.
6
Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations.病毒相关性哮喘加重的流行病学与免疫发病机制
J Asthma Allergy. 2023 Sep 26;16:1025-1040. doi: 10.2147/JAA.S277455. eCollection 2023.
7
Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy.内皮糖萼损伤在 SARS-CoV-2 感染中的作用：分子机制与潜在靶向治疗。
Mediators Inflamm. 2023 Aug 29;2023:6685251. doi: 10.1155/2023/6685251. eCollection 2023.
8
Predictors of pulmonary embolism in hospitalized patients with COVID-19.新型冠状病毒肺炎住院患者肺栓塞的预测因素
Thromb J. 2023 Jul 3;21(1):73. doi: 10.1186/s12959-023-00518-y.
9
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance.接受家庭远程监测的 COVID-19 哮喘门诊患者的特征与结局
ERJ Open Res. 2022 Oct 24;8(4). doi: 10.1183/23120541.00012-2022. eCollection 2022 Oct.
10
Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study.COVID-19 感染住院患者吸入环索奈德的临床获益：一项回顾性研究。
BMC Pulm Med. 2022 Sep 28;22(1):368. doi: 10.1186/s12890-022-02168-8.
哮喘患者痰液细胞中的 COVID-19 相关基因。与人口统计学特征和皮质类固醇的关系。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. doi: 10.1164/rccm.202003-0821OC.
4
Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza.哮喘患者流感住院期间的全身和局部炎症模式。
Eur Respir J. 2019 Oct 24;54(4). doi: 10.1183/13993003.00949-2019. Print 2019 Oct.
5
Preexisting Type 2 Immune Activation Protects against the Development of Sepsis.预先存在的2型免疫激活可预防脓毒症的发生。
Am J Respir Cell Mol Biol. 2017 Nov;57(5):628-630. doi: 10.1165/rcmb.2017-0277LE.
6
Asthma Is Associated with a Lower Risk of Sepsis and Sepsis-related Mortality.哮喘与较低的脓毒症风险及脓毒症相关死亡率相关。
Am J Respir Crit Care Med. 2017 Sep 15;196(6):787-790. doi: 10.1164/rccm.201608-1583LE.
7
Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs.过表达小鼠模型证明了 Muc5ac 在肺部的保护作用。
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16528-33. doi: 10.1073/pnas.1206552109. Epub 2012 Sep 24.
8
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.2009-2010 年英国甲型 H1N1 流感大流行两个波次期间全国住院患者队列的临床结局预测因素。
Thorax. 2012 Aug;67(8):709-17. doi: 10.1136/thoraxjnl-2011-200266. Epub 2012 Mar 10.
9
Increased H1N1 infection rate in children with asthma.儿童哮喘患者 H1N1 感染率上升。
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1275-9. doi: 10.1164/rccm.201109-1635OC. Epub 2012 Feb 23.
10
Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009.2003-2009 年季节性或大流行性流感住院的哮喘儿童。
Pediatrics. 2011 Jul;128(1):e27-32. doi: 10.1542/peds.2010-3343. Epub 2011 Jun 6.